,i #aah? ,,congress #a/ ,session ,h4 ,r4 #dfbf ,,9 ,,! ,,h\se ,,( ,,repres5tatives ,july #ac1 #bjbc,mrs4 ,mill]-,meeks 7= h]self1 ,mrs4 ,kiggans ( ,virg9ia1 ,ms4 ,gre5e ( ,georgia1 ,mrs4 ,bice1 ,ms4 ,salaz>1 ,mrs4 ,*avez-,de,remer1 ,ms4 ,malliotakis1 ,mrs4 ,kim ( ,cali=nia1 ,mrs4 ,h>%b>g]1 & ,ms4 ,mace7 introduc$ ! foll[+ bill2 :i* 0 ref]r$ to ! ,committee on ,en]gy & ,comm]ce ,a ,,bill ,to enc\rage sponsors ( oral contraceptive drugs to submit applications = ! approval ( su* drugs z ov]-!-c\nt]1 & = o!r purposes4 #a4 ,%ort title ,?is ,act may be cit$ z ! ,orally ,tak5 ,contraception ,act ( #bjbc or ! ,,otc ,act ( #bjbc4 #b4 ,,fda guidance on *ang+ m>ket+ /atus ( contraceptive drugs to ov]-!-c\nt] 7a7 ,9 g5]al ,n lat] ?an #a ye> aft] ! date ( ! enactm5t ( ?is ,act1 ! ,secret>y ( ,heal? & ,human ,s]vices act+ ?r\gh ! ,commission] ( ,food & ,drugs1 = purposes ( enc\rag+ sponsors ( oral contraceptive drugs to submit applications = ! approval ( oral contraceptive drugs to be m>ket$ )\t be+ subject to section #ejc7;b77#a7 ( ! ,f$]al ,food1 ,drug1 & ,cosmetic ,act 7#ba ,u4,s4,c4 #cec7;b77#a771 %all issue guidance t-- 7#a7 provides a detail$ description ( ! review process = !-- 7,a7 approval ( drugs "u section #eje ( ! ,f$]al ,food1 ,drug1 & ,cosmetic ,act 7#ba ,u4,s4,c4 #cee72 7,b7 m>ket+ au?orization ( ov]-!-c\nt] drugs "u section #eje;,g ( su* ,act 7#ba ,u4,s4,c4 #cee;h72 & 7,c7 lic5sure ( biological products "u section #cea ( ! ,public ,heal? ,s]vice ,act 7#db ,u4,s4,c4 #bfb72 7#b7 provides = backgr\nd in=mation on oral contraceptive drugs1 includ+-- 7,a7 ! hi/ory ( approval1 m>ket+ au?orization1 or lic5sure ( oral contraceptive drugs "u ! provisions ( law specifi$ 9 p>agraph 7#a72 7,b7 ! /&>ds us$ to grant su* approval1 m>ket+ au?orization1 or lic5sure2 & 7#c7 specifies ! b5efit-risk consid]ations t ! ,secret>y uses to det]m9e :e!r to approve1 au?orize = m>ket+1 or lic5se oral contraceptive drugs2 & 7#d7 details ! ,secret>y's ef=ts to facilitate ! developm5t ( oral contraceptive drugs to be m>ket$ )\t be+ subject to section #ejc7;b77#a7 ( ! ,f$]al ,food1 ,drug1 & ,cosmetic ,act 7#ba ,u4,s4,c4 #cec7;b77#a774 7b7 ,label+ compreh5sion /udy 7#a7 ,9 g5]al ,! ,secret>y ( ,heal? & ,human ,s]vices1 act+ ?r\gh ! ,commission] ( ,food & ,drugs1 %all complete a /udy on consum] compreh5sion ( ! label+ ( oral contraceptive drugs4 7#b7 ,issues to be /udi$ ,! /udy requir$ by p>agraph 7#a7 %all address h[ ! label+ ( oral contraceptive drugs c\ld be improv$ to increase consum] compreh5sion ( ! in=mation convey$ 9 su* label+1 includ+ ! prop] use ( su* drugs & = :om su* drugs are indicat$4 7#c7 ,completion2 publication ,! ,secret>y ( ,heal? & ,human ,s]vices1 act+ ?r\gh ! ,commission] ( ,food & ,drugs1 %all-- 7,a7 n lat] ?an #a ye> aft] ! date ( ! enactm5t ( ?is ,act1 complete ! /udy requir$ by p>agraph 7#a72 & 7,b7 publi% ! results ( su* /udy 9 conjunction ) ! issuance ( ! guidance requir$ by subsection 7a74 7c7 ,oral contraceptive drug def9$ ,9 ?is section1 ! t]m oral contraceptive drug means a drug 7z def9$ 9 section #bja7;g77#a7 ( ! ,f$]al ,food1 ,drug1 & ,cosmetic ,act 7#ba ,u4,s4,c4 #cba7;g77#a77 t-- 7#a7 is us$ to prev5t f]tilization2 7#b7 is adm9i/]$ orally2 7#c7 is solely int5d$ = r\t9e use & n z an em]g5cy contraceptive2 7#d7 does n include any drug1 sub/ance1 or comb9ation ( drugs or sub/ances us$ aft] f]tilization2 & 7#e7 does n include any drug or o!r me?od us$ to t]m9ate a pregnancy4